- Home
- FEIM vs SCPH Comparison
FEIM vs SCPH Comparison
Compare FEIM & SCPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FEIM
- SCPH
- Stock Information
- Founded
- FEIM 1961
- SCPH 2013
- Country
- FEIM United States
- SCPH United States
- Employees
- FEIM N/A
- SCPH N/A
- Industry
- FEIM Electrical Products
- SCPH Biotechnology: Pharmaceutical Preparations
- Sector
- FEIM Industrials
- SCPH Health Care
- Exchange
- FEIM Nasdaq
- SCPH Nasdaq
- Market Cap
- FEIM 173.6M
- SCPH 173.6M
- IPO Year
- FEIM N/A
- SCPH 2017
- Fundamental
- Price
- FEIM $15.74
- SCPH $2.50
- Analyst Decision
- FEIM
- SCPH Strong Buy
- Analyst Count
- FEIM 0
- SCPH 3
- Target Price
- FEIM N/A
- SCPH $14.00
- AVG Volume (30 Days)
- FEIM 63.5K
- SCPH 637.9K
- Earning Date
- FEIM 03-13-2025
- SCPH 03-19-2025
- Dividend Yield
- FEIM 6.35%
- SCPH N/A
- EPS Growth
- FEIM 604.98
- SCPH N/A
- EPS
- FEIM 2.41
- SCPH N/A
- Revenue
- FEIM $65,400,999.00
- SCPH $36,332,000.00
- Revenue This Year
- FEIM N/A
- SCPH $134.20
- Revenue Next Year
- FEIM N/A
- SCPH $99.40
- P/E Ratio
- FEIM $6.37
- SCPH N/A
- Revenue Growth
- FEIM 24.10
- SCPH 167.28
- 52 Week Low
- FEIM $8.62
- SCPH $2.21
- 52 Week High
- FEIM $20.33
- SCPH $5.65
- Technical
- Relative Strength Index (RSI)
- FEIM 49.82
- SCPH 32.57
- Support Level
- FEIM $15.17
- SCPH $2.87
- Resistance Level
- FEIM $17.41
- SCPH $3.08
- Average True Range (ATR)
- FEIM 0.78
- SCPH 0.21
- MACD
- FEIM 0.03
- SCPH -0.05
- Stochastic Oscillator
- FEIM 25.45
- SCPH 29.96
About FEIM Frequency Electronics Inc.
Frequency Electronics Inc is engaged in the design, development, and manufacture of high-precision timing, and frequency control products for space, air, sea, and terrestrial applications. The company has FEI-NY and FEI-Zyfer reportable segments. It derives the majority of its revenues from the FEI-NY segment. FEI-NY segment operations consist principally of precision time and frequency control products used in three principal markets namely communication satellites (both commercial and U.S. Government-funded); terrestrial cellular telephone or other ground-based telecommunication stations; and other components and systems for the U.S. military.
About SCPH scPharmaceuticals Inc.
scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.